clinical trial enrichment

ExOcular is developing a portfolio of blood-based multiplex tests that measure disease-specific biomarkers isolated from exosomes to help manage severe eye diseases, initially focusing on diabetic retinopathy and age-related macular degeneration. Its analysis algorithms generate a quantitative Disease Severity Score to support early diagnosis, prognosis, and treatment monitoring. Headquarters and lab are located at the University of Colorado Anschutz Medical Campus.

Read more

analysis algorithms generating Disease Severity Scorebiomarker measurementexosome isolationmultiplex biomarker panelstherapy monitoring